Home › Funds › Meridiem Capital Partners LP › EW

Meridiem Capital Partners LP position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Meridiem Capital Partners LP reported holding 808,362 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$69.8M, representing 3.27% of its reported portfolio and ranking #5 among its reported holdings. Meridiem Capital Partners LP has disclosed EW holdings in 6 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)808.36K sh
Reported value held$69.78M
Portfolio Weight3.27%
First reportedQ4 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Meridiem Capital Partners LP's EW position evolved

Meridiem Capital Partners LP first disclosed a stake in EW in Q4 2024 at 42,843 shares (US$3.2M). The position peaked in Q2 2026 at 858,921 shares, worth US$77.7M. Across 6 filings, Meridiem Capital Partners LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 808,362 shares valued at US$69.8M — a reduction of -50,559 shares quarter over quarter.. Notable position changes include a 770% increase in Q1 2025 (shares rose 8% over the following quarter), a 103% increase in Q1 2026 (shares rose 13% over the following quarter), a 268% increase in Q2 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 42.84K $3.17M New
Q1 2025 372.82K $27.02M Add
Q4 2025 114.77K $9.78M New
Q1 2026 233.19K $18.67M Add
Q2 2026 858.92K $77.70M Add
Q3 2026 808.36K $69.78M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 29 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Meridiem Capital Partners LP held EW?

Meridiem Capital Partners LP has disclosed EW holdings in 6 of the last 8 reported quarters, going back to Q4 2024.

What is Meridiem Capital Partners LP's current position in EW?

As of Q3 2026, Meridiem Capital Partners LP holds 808.36K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $69.78M, representing 3.27% of its reported portfolio and ranking #5.

Has Meridiem Capital Partners LP been buying or selling EW?

In the latest 13F filing (Q3 2026), Meridiem Capital Partners LP reduced its position in EW. The position peaked in Q2 2026 at 858.92K shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.